Hangdi Wu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Author Correction: Multiplexed bulk and single-cell RNA-seq hybrid enables cost-efficient disease modeling with chimeric organoids.
Journal: Nature communications
Published: June 05, 2024
Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 09, 2023
Generating Kidney Organoids in Suspension from Induced Pluripotent Stem Cells.
Journal: Journal of visualized experiments : JoVE
Published: September 07, 2023
Establishment of the induced pluripotent stem cell line (NCKDi005-A) from a male patient with Alport syndrome carrying a homozygous frameshift mutation in the COL4A4 gene.
Journal: Stem cell research
Published: October 11, 2021
Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carrying a homozygous mutation in COL4A3 gene.
Journal: Stem cell research
Published: August 26, 2021
Establishment of an induced pluripotent stem cell line (NCKDi003-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p. T277P (c. 829A > C) in the CLCN5 gene.
Journal: Stem cell research
Published: July 15, 2021
Generation of the induced pluripotent stem cell line (NCKDi002-A) from a 22-year-old patient with Focal Segmental Glomerular Sclerosis carrying a heterozygous mutation in WT1 gene.
Journal: Stem cell research
Published: February 26, 2021
Generation of induced pluripotent stem cell line (NCKDi001-A) from a 19-year-old patient with a novel COL4A5 gene mutation in Alport syndrome.
Journal: Stem cell research
Published: July 14, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026